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ABSTRACT
BACKGROUND – Despite decades of intensive anti-tobacco initiatives, millions of people are still 
smoking. The health authorities are seeking new tools and extended knowledge. Screening pro-
grams may, in addition to the potential health benefits from early detection of smoking related 
diseases, also increase smoking cessation among participants. This study examines the effect of 
screening participation by comparing the smokers’ cessation hazard in screening years to non-
screening years. METHODS – All smokers (n=10,471) participated in a three-wave cardiovascular 
screening and were followed up over a maximum of 14 years. The panel was merged with ad-
ministrative registers. We used a flexible discrete-time duration model to investigate the effect 
of the screening program while simultaneously accounting for the possible influence of personal 
characteristics, addiction indicators, economic factors, health status and health changes. Specifi-
cally, we examined and compared long-term smokers (LT; smoked ≥25 years) with short-term (ST; 
smoked ≤ 5 years) and medium-term (MT; smoked 10-20 years) smokers. RESULTS – We found 
that 29% of LT smokers quitted smoking during the follow-up whereas 32% of MT and 48% of ST 
smokers reported the same. The screening participation years stood out as especially important 
for all groups. The impact of the first screening was particularly high, and for the first two screen-
ings, the effect was higher for long-term smokers than for the smokers with shorter smoking 
careers. Receiving an abnormal test result was not associated with a significant increase in ces-
sation hazard for any group of smokers. CONCLUSIONS – The substantial effect of being invited 
to and participating in a screening appears robust, and may prove useful when discussing future 
policies for smoking cessation. This paper suggests that further initiatives for consultations with 
health personnel, in this case through a screening program, could increase the quitting hazard.
KEYWORDS – cigarette cessation, duration model, quitting hazard, screening, long-term smokers, 
health status and shocks, policy intervention
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Introduction 
Measured by the substantial drop in the 
prevalence of daily cigarette smokers, the 
western anti-tobacco policy has been rela-
tively successful. Still, further reduction is 
an important target for health authorities. 
Expansion of many well-known and fre-
quently used means for reducing cigarette 
consumption (e.g. increased tobacco taxes) 
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may have limited political appeal or prove 
inefficient. Many countries have already 
implemented an extensive set of smoking 
regulations, and further use of traditional 
anti-smoking campaigns on current smok-
ers may have less effect as the harmful-
ness of smoking is common knowledge. 
Policy makers and others working for an 
improved “health of the nation” therefore 
seek new tools as well as improved knowl-
edge about the efficiency of traditional 
means to combat cigarette smoking (Zhu, 
Lee, Zhuang, Gamst, & Wolfson, 2012; 
Warner & Mendez, 2010). 
One suggestion for increasing the ces-
sation rate is more direct and extended 
contact between the health care sector 
and the smokers, here exemplified by the 
use of screening programs. Screening pro-
grams may contribute to increased pub-
lic health by early detection of diseases, 
like for instance suggested by the results 
of the National Lung Screening Test with 
respect to participants’ reduced lung can-
cer mortality (Aberle et al., 2011). In ad-
dition, screening programs may also in-
fluence participants’ smoking habit. By 
simply being invited to and participating 
in such a program, smokers are reminded 
of, and confronted with, their individual 
health risk. For smokers who have already 
considered to reduce or cease smoking, 
the screening participation may be suf-
ficient to actually take action. Screening 
programs might, however, also have the 
opposite effect if smokers with a negative 
(normal) screening outcome think they are 
“safe” and therefore continue their ciga-
rette consumption. Thus, the screening’s 
effect on smoking behaviour is not a priori 
given.
Empirical investigations have so far not 
yielded conclusive results. Observational 
studies have found higher quitting rates 
among screening participants compared 
to the general population of smokers (see 
e.g. Taylor et al., 2007; Ostroff, Buckshee, 
Mancuso, Yankelevitz, & Henschke, 2001). 
Generalizing from this finding is difficult, 
however, as participants may deviate from 
other smokers on outcome-related charac-
teristics. A few randomized control trials 
(RCT) have been conducted: Ashraf et al. 
(2009) tested whether the treatment group 
(participated in a lung screening) had a 
higher cessation rate than the comparison 
group (received no CT screening) among 
a group of smokers. They found similar 
quit rates for both groups at the 1-year 
follow-up. A Dutch-Belgian RCT found 
a slightly lower smoking abstinence rate 
among the group receiving lung screen-
ing than among the control group (van 
der Aalst, van den Bergh, Willemsen, de 
Koning, & van Klaveren, 2010). The dif-
ference was no longer significant when an 
intention-to-treat analysis was conducted. 
Shi & Iguchi (2011) found no difference 
in quitting rates between a group receiv-
ing lung screening every 4-6 months and 
a group receiving annual screenings. Barry 
et al. (2012) reported similar smoking ces-
sation rates in the trial arm and the con-
trols among a group of current smokers 
(n=6,807). The studies confirmed, how-
ever, that trial participants were more in-
clined to stop smoking than the general 
population of smokers. 
We contribute to this literature by exam-
ining the possible effect of screening from 
a new angle, namely by comparing cessa-
tion rates in screening years to cessation 
rates in non-screening years for a group of 
smokers who all participated in an exten-
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sive three-wave cardiovascular screening 
program in Norway. The Norwegian trend 
in smoking prevalence is in line with 
those of other Western countries (WHO, 
2013; Lopez, Collishaw, & Piha, 1994). By 
international standards our panel data set 
was fairly rich, as it had a long observation 
window (up to 14 years), covered a large 
number of participants (n=10,471) and of-
fered four categories of controls: personal 
characteristics; health status and health 
shock variables; indicators of addiction 
status; economic factors. A substantial 
part of the data set stems from adminis-
trative registers, which may have reduced 
problems like recall bias and imprecise re-
porting. The panel design is distinctive in 
that records from a three-wave panel with 
a distance of roughly five years between 
the waves are `superimposed’ on annual 
register information. 
We further contribute by examining 
whether the screening effect differs among 
three groups of smokers. As, by general 
belief, people who have smoked for dec-
ades are more “immune” to anti-smoking 
interventions than less habitual smokers, 
we distinguished smokers according to the 
length of their pre-sample smoking career: 
Short-term smokers (ST-smokers) with ca-
reers up to five years, Medium-term smok-
ers (MT-smokers) with careers between 10 
and 20 years, and Long-term smokers (LT-
smokers) with careers of at least 25 years. 
Using the same model setup we contrasted 
the results for LT-smokers to the results of 
smokers with shorter careers, a priori al-
lowing for group differences in the coef-
ficient values. 
Previous studies have also examined 
whether participants’ quitting rates are 
influenced by the screening outcome. Al-
though many have found that those re-
ceiving a negative test result are less likely 
to quit smoking, the results are some-
what mixed (see e.g. van der Aalst, van 
Klaveren, van den Bergh, Willemsen, & de 
Koning,  2011; Anderson et al., 2009; Styn 
et al., 2009; Townsend et al., 2005; Ostroff 
et al., 2001). In addition to examining the 
possible effect of screening outcome we 
also examine whether participants’ initial 
health and changes in health status over 
time impact the cessation rate, i.e. we are 
able to take into account an extensive set 
of self-reported and objective health meas-
ures.
Data and sample description
Our main body of data is extracted from 
a comprehensive cardiovascular screen-
ing program conducted by the National 
Health Screening Service (presently: the 
Norwegian Institute of Public Health). 
The program involved three screenings, 
in three among the nineteen counties over 
the 1974–1988 period. For practical and 
institutional reasons the screenings were 
not synchronized across the counties, tak-
ing place approximately every fifth year1. 
In the first screening all inhabitants aged 
35–49 years, and a 10% random sample of 
persons between 20 and 34 years old, were 
invited to participate. The target groups for 
the second and third screenings combined 
previous participants and new cohorts. 
The three screening dates will be denoted 
as R1, R2, and R3.
Altogether 65,624 subjects were invited 
to the first screening in the three coun-
ties, and 88% participated (Bjartveit, Foss, 
Gjervig, & Lund-Larsen, 1979). Of all those 
invited, the attendance rates for the second 
and third screenings were 88% and 84%, 
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respectively. Participants were asked to 
fill out a questionnaire at home and bring 
it to the screening station. Information on 
any history of cardiovascular diseases, 
diabetes, use of anti-hypertensives, symp-
toms of cardiovascular diseases, physical 
activity during leisure time and at work, 
smoking habits, stress factors in social life, 
and family history of coronary heart dis-
eases were recorded. An additional ques-
tionnaire was handed out at the screening 
station and the participants were asked to 
complete it at home and return it by mail. 
A simple health examination was carried 
out at the screening station. Height and 
weight, systolic and diastolic blood pres-
sure were measured according to a stand-
ard protocol and a non-fasting blood sam-
ple was drawn and analysed for serum to-
tal cholesterol and triglycerides. At R1 and 
R2 a mass miniature chest x-ray was taken. 
In the statistical analyses presented in sec-
tion 3, results from these medical tests are 
included along with responses from the 
questionnaires.
The individuals included in the current 
sample satisfied three criteria: they were 
screened for the first time in 1975–1978, 
stated that they were daily cigarette smok-
ers then, and participated in both follow-
ups2. The number of participants was 
12,499. As smoking history is assumed 
to influence on the likelihood of quitting, 
we accounted for the variation in partici-
pants’ smoking careers prior to R1. We 
thus defined three groups according to 
their reported number of years as a smoker 
prior to entering the study: 1) Short-term 
smokers (ST-smokers), having smoked up 
to 5 years at R1, n=905; 2) Medium-term 
smokers (MT-smokers), having smoked 
10–20 years at R1, n=7,641; and 3) Long-
term smokers (LT-smokers), having 25 
years or more at R1, n=1,925. To increase 
the probability of detecting any group dif-
ferences we excluded some career lengths 
when defining the groups, i.e. we ran-
domly excluded those with 6-9 years and 
21–24 years of smoking prior to R1. This 
reduced the final sample size to 10,471, as 
some of the participants did not belong to 
either of the ST, MT and LT smoker groups 
thus defined. 
The data from the screening were 
merged with information for each of the 
years 1974-1988 from administrative reg-
isters (Statistics Norway) on the individu-
al’s income, education, marital status, and 
household size. Annual cigarette prices 
were obtained from the same source. Thus, 
the contiguous, unbalanced panel dataset 
had information on more variables in the 
screening years than in the non-screening 
years, providing a composite of a 3-wave 
and a 14-year panel.
Descriptive statistics for the four catego-
ries of controls are given in Table 1 and 
further details are provided in tables A1 
and A2, see Appendix.
To assess the effect of the screening 
participation on smoking cessation we in-
cluded dummies for the screening years 
(screening1-3), which, because the screen-
ing periods were not synchronized across 
individuals, are (individual, time)-sub-
scripted. We assume that if a test result af-
fected an individual’s smoking cessation, 
it would do so in the same year as the mes-
sage was received, and therefore created 
dummies with value equal to one for the 
respective screening years if an unfavour-
able test result (as determined by medical 
experts) was revealed to the participants 
(badreport1-3). As the possible effect of 
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Table 1. Summary statistics, subgroups and full sample
Full sample Long term smokers
(smoked ≥25 years)
Medium term smokers
(smoked 10–20 years)
Short term smokers
(Smoked up to 
5 years)
Variable Mean St.dev Mean St.dev Mean St.dev Mean St.dev
Demographics 
(dummies)
Male 0.550 0.497 0.798 0.401 0.507 0.500 0.303 0.460
Age 38.87 5.845 44.31 2.722 38.49 4.387 32.66 8.841
Educ1 0.513 0.500 0.609 0.488 0.509 0.500 0.382 0.486
Educ2 0.426 0.494 0.355 0.479 0.425 0.494 0.535 0.499
Educ3 0.049 0.216 0.024 0.153 0.052 0.222 0.072 0.258
Educ4 0.008 0.086 0.006 0.079 0.009 0.094 0.004 0.066
Children 0.764 0.424 0.684 0.465 0.800 0.400 0.688 0.463
New baby 0.018 0.133 0.003 0.057 0.011 0.104 0.030 0.171
Single 0.109 0.312 0.091 0.288 0.087 0.282 0.190 0.391
Married 0.843 0.364 0.845 0.362 0.858 0.348 0.737 0.440
Div-wid 0.063 0.243 0.065 0.247 0.033 0.180 0.070 0.256
Health (dummies)
Symptoms (R1) 0.026 0.159 0.030 0.170 0.023 0.148 0.025 0.157
Illness (R1) 0.043 0.203 0.089 0.285 0.034 0.181 0.024 0.154
Bmihigh (R1) 0.362 0.481 0.477 0.500 0.340 0.474 0.331 0.471
Actwork (R1) 0.384 0.487 0.460 0.499 0.375 0.484 0.304 0.460
Exercise (R1) 0.212 0.409 0.205 0.404 0.218 0.413 0.170 0.376
Disabled (R1) 0.016 0.124 0.029 0.168 0.012 0.110 0.017 0.128
Sympshock12 0.008 0.091 0.013 0.115 0.007 0.081 0.011 0.104
Sympshock23 0.008 0.087 0.008 0.091 0.007 0.083 0.007 0.085
Illshock12 0.017 0.130 0.035 0.183 0.014 0.117 0.014 0.116
Illshock23 0.022 0.147 0.037 0.190 0.019 0.137 0.013 0.113
Badreport1 0.017 0.130 0.024 0.155 0.016 0.125 0.013 0.113
Badreport2 0.016 0.127 0.023 0.150 0.015 0.123 0.012 0.111
Badreport3 0.008 0.102 0.009 0.118 0.007 0.097 0.006 0.102
Addiction
Debut_age 21.68 5.664 17.78 2.567 22.06 4.495 29.09 9.120
Number_cig 13.42 6.619 15.23 7.084 13.18 6.324 9.71 5.685
Economic
Cigprice (ln) 1.032 5.629 1.073 5.618 1.037 5.633 0.863 5.595
Income (ln) 5.914 0.891 5.941 0.846 5.793 0.896 5.623 1.135
Dep. Var. (dummy)
Quit smoking 0.034 0.180 0.029 0.167 0.033 0.178 0.056 0.231
No of obs. 122,974 19,638 75,248 7,628
No of persons 12,499 1,925 7,641 905
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the test results on smoking participa-
tion would only be registered at the next 
screening, the badreport3 variable at R3 
was left out of the analyses. 
Demographic variables: Table 1 shows 
that there were roughly equal proportions 
of men and women in the full sample 
(mean of dummy male=0.55), with large 
differences across the three subgroups, 
e.g., 80% of the LT-smokers were men 
(mean of LT-male dummy=0.798). Mean 
age at the start of the survey was 39 years 
(age), which increased from 33 to 44 years 
across subgroups with increasing length 
of the smoking career. More than half 
of the respondents had left school after 
the mandatory minimum schooling (≤ 
9 years). Three out of four had children 
younger than 16 years at the start of the 
study (mean of dummy children = 0.764) 
and 2% had a new baby in that year (mean 
of dummy new baby = 0.018). The over-
all share of unmarried was 11% (mean of 
dummy single=0.109), while 6% became 
separated, divorced or widowed during 
the study period (mean of dummy div-wid 
=0.063). 
Indicators of addiction: Two tobacco ad-
diction indicators were included: the start-
ing age of smoking (debut_age) and the 
log of the maximum number of cigarettes 
smoked per day (number_cig). Mean start-
ing age was 21 years, but declined signifi-
cantly with the number of years as a smok-
er (29 years for ST- and 18 years for LT-
smokers). Also, the mean number of daily 
cigarettes varied with smoking experience; 
LT-smokers reported to smoke 15 cigarettes 
per day compared to 13 and 10 cigarettes 
for MT- and ST-smokers, respectively. 
Price and income indicators: We let the 
annual log-increase of the CPI-deflated 
price of a 20-pack of Marlboro represent 
the general price development for ciga-
rettes (yeart - yeart-1), as prices of the vari-
ous cigarette brands in Norway tend to 
move in parallel. Since current smokers 
can be said to have already “absorbed” 
the previous year’s price level, we as-
sumed that it is the relative price increase 
that could potentially impact the quitting 
hazard. Family income data (based on as-
sessments for tax purposes) was deflated 
by the CPI and normalized by family size 
(i.e., divided by the square root of fam-
ily numbers, including children below 16 
years of age). Considering the high propor-
tion of married respondents and female 
home-makers with unpaid employment, 
family income was preferred to individual 
income. For a small subsample, income 
data were missing or reported as zero in 
certain years. Instead of deleting these 
units, at the risk of introducing selection 
bias, we replaced the missing values with 
the individual’s mean income from the 
other years. 
Health status and health shock indica-
tors. At the start of the study period, re-
spondents had a certain health status and 
a stock of information regarding their sta-
tus. At R1, R2, and R3 some new informa-
tion was provided, which was supple-
mented with results from the medical tests 
announced after the screening. This infor-
mation - which to some respondents could 
have emerged as health shocks - may have 
affected the decision to continue or to 
quit smoking. We have incorporated these 
ideas by including: (i) health status vari-
ables at R1 (self-reported and registered by 
health personnel), (ii) dummies indicating 
worsened health status from R1 to R2, or 
from R2 to R3; and (iii) test results from 
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blood tests and x-rays for the correspond-
ing screening year. 
A significantly higher proportion of LT-
smokers than smokers in the other groups 
had experienced symptoms of a cardio-
vascular illness at R1 (indicated by the 
dummy symptoms), had a cardiovascular 
disease or diabetes (dummy illness) or 
had a body mass index (BMI) above 25 
(dummy bmihigh) as presented in Table 1. 
Long-term smokers also reported a higher 
frequency of having a physically demand-
ing job (dummy actwork) and a higher fre-
quency of exercise (dummy exercise) than 
the group with a smoking career less than 
6 years. More LT-smokers received disabil-
ity pension (dummy disabled) than both of 
the other groups.
Negative health shocks, recorded as 
dummies at R2 and R3, may have started 
to influence smoking behaviour prior to 
that date (e.g., the individuals may have 
experienced symptoms indicating lung 
problems soon after the previous screen-
ing). As described in Table A2, this is 
taken into account by the creation of the 
sympshock12-23 and illshock12-23 varia-
bles. Long-term smokers reported a higher 
prevalence of symptoms or illnesses at R2 
and R3 than the other two groups. 
Dependent variable: Over the study pe-
riod, 29% of the LT-smokers reported to 
cease smoking compared to 32% and 48% 
among the MT- and ST- smokers. The quit-
ters were asked whether they had termi-
nated the habit less than 3 months, 3-12 
months, 1-5 years or more than 5 years 
prior to the date of recording. From these 
entries we constructed a binary quitting 
variable based on the year the individuals 
ceased smoking (if they quit smoking at 
all). For the 1–5 years category the quitting 
year is constructed from the information 
the respondents gave regarding the num-
ber of years as a smoker at each screening3. 
Econometric model
Studies examining cigarette quitting ei-
ther employ a discrete choice framework 
or duration models (Forster and Jones, 
2001). Many logistic and probit models of 
quitting are found in the literature, see e.g. 
Hyland et al. (2004), Ross, Powell, Tauras 
and Chaloupka (2005), and DeCicca, Ken-
kel and Mathios (2008), while time-series 
analyses using the smoking participation 
rate as the dependent variable have proved 
less useful. This is because changes in such 
rates cannot distinguish between changes 
in the starting and the quitting rate, and 
factors influencing the two rates may differ 
(Douglas 1998). 
We employed a discrete-time duration 
model (Jenkins, 2005). A duration model 
focuses on the risk of transition (hazard) 
from one state to another (e.g., from smok-
ing to non-smoking) while taking into ac-
count control variables and duration de-
pendence. Compared to the well-known 
Cox regression model in survival analysis, 
the current model has two advantages: i) 
the duration dependence is specified and 
ii) we can easily account for time vary-
ing covariates like prices, income etc. We 
modelled the duration dependence flex-
ibly using a piecewise constant specifica-
tion based on year dummies and allowed 
for stepwise changes in the coefficient vec-
tor by splitting the sample in three groups 
according to the length of pre-sampling 
the smoking careers. In modelling the quit-
ting hazard, we kept attention on two time 
variables: time in process as a smoker and 
time in the screening process. This is be-
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cause a respondent’s inclination to cease 
smoking is likely to depend on how long 
he/she has been addicted to smoking and 
on how long he/she has been scrutinized 
by health authorities and has accumulated 
health screening information. 
In addition to the set of covariates, we 
also accounted for unobserved heterogene-
ity. Several ways of modelling heterogene-
ity in survival processes were considered; 
the Akaike and the Bayesian information 
criteria (AIC and BIC) suggested that the 
gamma specification was superior to the 
normal and the discrete multinomial dis-
tribution, so the results shown in Table 2 
are based on a cloglog model with gamma 
distributed heterogeneity. 
The model and the method are described 
in more details in the Appendix. All data 
analyses were completed using Stata ver-
sion 12.1.
Results
The non-parametric hazard rates for ST-, 
MT- and LT-smokers are presented in Fig-
ure 1, where the x-axis represents the time 
elapsed since the start of the study. For 
all groups there was a downward slop-
ing trend indicating that the quitting rate 
declined over time. The trends each had 
three peaks, which may well reflect the 
three rounds of screening but alternative 
explanations are possible. For all smok-
ers, period 2 represents R1 (the year of 
the first screening), R2 occurred in period 
7 for the majority of the respondents but 
varied somewhat, as did the period when 
the screening was terminated at R3. 
Examining the peaks more closely, we 
found that among the 1,151 smokers who 
ceased smoking in the first screening year, 
39% reported to have done so within the 3 
month period before visiting the screening 
station, 21% quit 3 to 12 months before the 
screening while 40% quit smoking after 
the screening that year. The corresponding 
numbers for the second screening year are 
37%, 30%, and 33%, respectively. As the 
third screening year marks the end of the 
follow-up period, only those who ceased 
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*The x-axis represents the number of time periods (years) 
since the start of the study
Figure 1. Hazard rates of cigarette quitting*
Short term smokers, smoked up to 5 years (n=905)
Medium term smokers, smoked 10–20 years 
(n=7,641)
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Long term smokers, smoked more than 24 years 
(n=1 925)
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Table 2. Regression results for frailty model with gamma distribution
 Dependent variable is the hazard of cigarette quitting
Interventions
Screening1 5.861*** 3.785 9.076 3.744*** 3.149 4.452 3.944*** 2.394 6.497
Screening2 3.619*** 1.855 7.059 2.406*** 1.663 3.482 2.209* 0.887 5.498
Screening3 1.504 0.711 3.181 1.932*** 1.276 2.924 3.179** 1.007 10.03
 
Demographics
Male 3.145*** 1.766 5.602 2.367*** 1.993 2.812 2.028*** 1.224 3.358
Age 1.062 0.986 1.143 0.973*** 0.956 0.990 0.845*** 0.743 0.961
Educ2 1.239 0.917 1.673 1.234*** 1.102 1.382 1.557** 1.083 2.237
Educ3 1.482 0.525 3.134 1.920*** 1.510 2.441 1.922** 1.037 3.560
Educ4 13.10** 1.859 92.36 2.344*** 1.397 3.933 11.88** 1.314 107.3
Children 1.008 0.771 1.316 1.223 1.074 1.391 0.831 0.611 1.129
New baby 1.255 0.339 4.639 1.079 0.792 1.469 1.889** 1.133 3.151
Single 0.613* 0.357 1.054 0.802* 0.641 1.003 0.567** 0.366 0.878
Div-wid 0.615 0.338 1.117 0.875 0.688 1.113 0.638 0.321 1.267
 
Health
Symptoms (R1) 3.293*** 1.507 7.194 0.905 0.624 1.311 1.401 0.527 3.727
Illness (R1) 0.913 0.550 1.517 1.434** 1.082 1.902 0.512 0.170 1.537
Bmi_high (R1) 1.610*** 1.154 2.246 1.262*** 1.113 1.430 1.301 0.867 1.952
Actwork(R1) 0.770 0.556 1.066 0.888* 0.786 1.004 0.698* 0.459 1.062
Exercise (R1) 0.906 0.635 1.293 1.138* 0.999 1.297 1.132 0.736 1.741
Disabled (R1) 0.401** 0.162 0.994 0.628* 0.362 1.090 1.701 0.381 7.604
 
Sympshock12  1.107 0.429 2.858 1.167 0.615 2.216 0.846 0.229 3.132
Sympshock23  0.838 0.171 4.104 0.740 0.266 2.059 0.870 0.097 7.827
Illshock12 1.107 0.634 1.934 1.720*** 1.206 2.452 1.286 0.408 4.057
Illshock23 2.033** 1.111 3.720 3.572*** 2.566 4.972 1.594 0.323 7.876
 
Badreport1 0.879 0.595 1.300 0.997 0.816 1.219 0.845 0.477 1.498
Badreport2 1.349 0.815 2.231 1.000 0.764 1.309 0.882 0.401 1.939
 
Addiction
Debut_age 1.023 0.942 1.110 1.079*** 1.057 1.101 1.187*** 1.046 1.347
No.cig  1.032 0.747 1.424 0.686*** 0.604 0.780 0.645** 0.449 0.927
 
Economic
Cigprice  0.995 0.978 1.013 1.012*** 1.004 1.020 1.009 0.987 1.031
Income  0.834** 0.717 0.969 1.026 0.963 1.093 1.203** 1.037 1.395
 
Gamma varience 3.948***  1.899 8.206  1.635*** 0.934 2.863 2.100**  0.808 5.454
LR-test statistic 12.984 (p>0.000) 16.178 (P>0.000) 5.513 (P>0.009)
Log likelihood -2356.324 -9867.170  -1435.063 
i) Please note: The constant term and the coefficients of the time dummies are suppressed but are available on request. 
* p<0.1; **p<0.05; ***p<0.01
Long term smokers
(smoked ≥25 years)
No of obs.=19,638
Medium term smokers
(smoked 10–20 years)
No of obs.=75,248
Short term smokers
(smoked up to 5 years)
No of obs.= 7,628
Exp(b)
95% confidence 
interval Exp(b)
95% confidence 
interval Exp(b)
95% confidence 
interval
Unauthenticated
Download Date | 1/7/15 1:23 PM
150 NORDIC STUDIES ON ALCOHOL AND DRUGS   V O L .  31.  2 0 1 4  . 2 
smoking before that date were registered 
as quitters.
The following analysis, based on the 
model and methods described in more de-
tails in the Appendix, examine whether 
the hazard pattern presented in Figure 1 is 
spurious or could be interpreted as a dis-
tinct effect of the screening participation 
and outcome. Table 2 presents the main 
estimation results block-wise. 
The first block of results shows that, 
even after taking account of several con-
trols, including health status and health 
shock indicators, the intervention (screen-
ing 1, 2 and 3) substantially influenced the 
quitting hazard for all groups. The impact 
of the first screening was particularly high 
for all groups, and for the first two screen-
ings the effect was higher for LT-smokers 
than for the smokers with shorter smoking 
careers. For the latter screening, however, 
the coefficient of screening 3 was statisti-
cally insignificant for LT-smokers. 
In all three “smoking-career categories”, 
males had a 2-3 times higher risk of quit-
ting, while age seems to be of importance 
for only ST- and MT-smokers, i.e. younger 
people were more likely to quit than older 
ones. Increased education was associated 
with increased probability of quitting. Our 
indicators of addiction did not come out 
as significant for the smoking cessation of 
LT-smokers. For ST- and MT-smokers the 
later the smoking debut and the smaller 
the number of daily cigarettes consumed, 
the higher the quitting hazard. Finally, 
changes in the deflated cigarette price af-
fected MT-smokers only.
 Health status at the start of the obser-
vation period affected the quitting hazard 
for MT- and LT-smokers only. In particular, 
having a high BMI tended to increase quit-
ting, while being disabled reduced it. Hav-
ing experienced symptoms at R1 substan-
tially affected LT-smokers only while MT-
smokers were affected by experienced ill-
ness. Illnesses occurring between two ad-
jacent screenings (illshock12, illshock23) 
significantly increased cessation for those 
who at R1 had smoked more than 10 years. 
On the other hand, receiving a bad report 
for the blood tests or the x-ray exams (bad-
report1 and 2) at R1 or R2 did not signifi-
cantly influence cessation for any group of 
smokers.
For every group of smokers and for all 
the parameterizations of latent heteroge-
neity considered, the null hypothesis of 
no random heterogeneity is rejected (see 
the bottom block of Table 2).
Sensitivity analyses
Redefining “true quitters”: Since many 
cigarette quitters are known to start again 
at some later point, the results above are 
potentially biased. Even though the indi-
vidual time-series in our sample are “cut 
off” when the respondents reported to 
have ceased smoking, the panel format of 
the data allows us to examine to what ex-
tent a relapse occurs. Doing this, we found 
that 27% of the smokers who quit in the 
first screening year reported to be daily 
cigarette smokers again at R2, and 25% of 
quitters in the R1-R2 period had started 
again at R3. To assess the magnitude of 
the potential bias, we re-ran the estima-
tions after having excluded all observa-
tions from the quitters for whom a relapse 
to smoking is known to have occurred at 
some later point. Relative to the results in 
Table 2, the impact of the first screening 
program was then somewhat diminished 
for all groups, the impact of the second 
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screening increased for MT- and LT-smok-
ers and became statistically insignificant 
for ST (p<0.17), while the effect of the 
third screening was virtually unchanged 
for MT- and LT-smokers and reduced for 
ST-smokers. Still, the main results appear 
fairly robust; being invited to and par-
ticipating in the program was important 
for the overall impetus to quit among all 
groups of smokers in the sample. 
Omitting screening dummies: Given the 
importance of the screening dummies on 
the quitting hazards we also wanted to 
examine whether excluding them would 
substantially affect the coefficients of the 
remaining covariates. The results, how-
ever, were very similar to those in Table 
2, that is, the same covariates were sta-
tistically significant and of basically the 
same magnitude. Not unexpectedly, the 
coefficients for the time dummies changed 
somewhat more, in particular the dum-
mies for periods 2 and 7 (corresponding 
to R1 and R2 for many respondents). They 
switched from being small and non-signif-
icant to becoming larger and significant.
Concluding remarks and policy 
implications
The strong and significant impact of the 
screening intervention on the quitting 
hazard is interesting and suggests that the 
screening itself could explain the peaked 
pattern in Figure 1. The first screening had 
the largest effect but the influence of subse-
quent screenings also seems considerable. 
As mentioned above, many of those who 
ceased cigarette smoking in the screening 
years reported to have done so during the 
three months immediately preceding the 
participation date. One interpretation of 
this finding is that the letter of invitation 
reminded and alerted the smokers of the 
negative health effects of their cigarette 
consumption and raised a fear of what the 
screening could possibly reveal. Thus, for 
a fraction of the smokers who may have 
already considered giving up the habit, 
the reminder seems to have been sufficient 
to take action. Also, the quitting hazard 
shortly after participation was high, which 
is in line with results reported of the ef-
fect of CT screenings on smoking cessation 
(Styn et al., 2009; Ostroff et al., 2001). 
This screening effect may seem to stand 
in some contrast to the results reported in 
the RCT studies mentioned above (Ashraf 
et al., 2009; van der Aalst et al., 2010; Shi & 
Iguchi, 2011; Barry et al., 2012). These RCT 
studies did not find an effect on smoking 
behaviour when comparing those who 
received lung cancer screening to their 
control groups. They all found, however, 
that screening participants had higher ces-
sation rates than the general population 
of non-participants. Our study differs in 
two important aspects; Firstly, our study 
participants constitute their own con-
trol groups, i.e. we compare the quitting 
hazard in screening years to that of non-
screening years for the same individuals. 
We find that the risk of cigarette quitting 
is higher in screening years than in non-
screening years for the smokers that con-
stitute our study group. Secondly, in our 
study, all inhabitants in certain age groups 
were invited to participate in the screen-
ing and the response rate was remarkably 
high (88%). This probably implies that the 
problem of self-selection into screening 
participation is less pronounced in this 
study than in studies with a more restrict-
ed population from which the participants 
were invited. Thus, one may expect that 
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the difference between the current sample 
and the general population is smaller here 
than in the above cited studies. 
Our coefficient estimates for the LT-
smokers, in particular the finding of an 
increased quitting hazard for this group, 
is undoubtedly important since the health 
gains for giving up smoking are substantial 
even for smokers with a long-standing ca-
reer (Taylor, Hasselblad, Henley, Thun, & 
Sloan, 2002; Ostbye and Taylor, 2004). Our 
results suggest that extended use of target-
ed screening programs or other consulta-
tions with health care providers may be 
particularly effective for this group of ex-
perienced smokers. Irrespective of wheth-
er or not there has been a “hardening” of 
remaining smokers in recent years (Lund, 
Lund, & Kvaavik, 2011; Docherty and Mc-
Neill, 2012), any cessation measures that 
seem to affect LT-smokers in particular 
should be of interest for policy makers 
and others concerned with promoting im-
proved health in the population.
Further, the finding that adverse health 
outcomes recorded at the start of the inter-
vention period and declining health status 
recorded during the study period seems 
to influence cessation more strongly for 
smokers with longer careers could suggest 
that LT-smokers with health issues may 
be particularly responsive to anti-tobacco 
initiatives. In contrast, neither having a 
cardiovascular disease or diabetes – or 
symptoms of such – nor being disabled, 
having a high BMI or exercising regularly 
are associated with an increased quitting 
hazard for ST-smokers. 
No group of smokers seemed to signifi-
cantly increase their quitting hazard in 
response to an unfavourable test result, 
supporting findings of e.g. van der Aalst et 
al. (2011), Cox et al. (2003), and Anderson 
et al. (2009), and suggesting that merely 
an indication of a negative health devel-
opment is not sufficient for reducing their 
smoking habits. Ashraf et al. (2009) and 
Styn (2009) on the other hand, reported 
higher cessation rates after abnormal test 
results or referral to a physician.
Increases in the cigarette tax/price did 
not seem very effective in influencing the 
overall cessation rate. While it is gener-
ally assumed that young smokers are more 
price-sensitive (Farrelly, Bray, Pechacek, & 
Woollery, 2001), it is still a matter of dis-
pute whether adults’ quitting behaviour 
is influenced by price increases (DeCicca 
and McLeod, 2008). Representing ciga-
rette prices by a relative price increase 
variable, we found that only MT-smokers 
are responsive to price changes. However, 
increased cigarette taxes could still affect 
smoking intensity (Chaloupka and Warn-
er, 2000; Gallet and List, 2003) and may 
thus indirectly increase the quitting haz-
ard rate. 
Our dataset, although being far from 
perfect, had a rather long observation win-
dow, many participants, and combined 
personal characteristics, indicators of ad-
diction status, economic factors, health 
status and health shock variables (subjec-
tive and objective), and governmental in-
terventions. This suggests that problems 
related to omitted variable bias, spurious 
effects interactions, etc., could be less pro-
nounced than in similar studies based on 
shorter data vectors. Also, the presence of 
data from administrative registers may to 
some extent reduce measurement prob-
lems (recall bias, etc.). The very high par-
ticipation rate suggests that the study sam-
ple is fairly representative of the general 
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population and that the risk of selection 
bias is reduced. Our use of self-reported 
smoking cessation as the outcome varia-
ble, and not any measures of intention-to-
quit, may be viewed as a further advantage 
of the study (IARC, 2008). 
The validity of self-reported smoking 
behaviour can be questioned, however, 
and it has been claimed that smokers are 
inclined to underestimate the amount 
smoked or to deny their smoking all to-
gether (Patrick et al., 1994). This report-
ing bias may be more pronounced for the 
number of cigarettes smoked per day than 
for whether or not they smoke. Many stud-
ies have examined the validity of self-re-
ported smoking behaviour by comparing 
survey results to biological markers, and 
like for instance Wong, Shields, Leatherd-
ale, Malaison and Hammond (2012), they 
generally suggest that self-reports provide 
accurate estimates of cigarette smoking 
prevalence. Adolescents and expecting 
mothers seem be somewhat more impre-
cise in their reporting (Patrick et al., 1994; 
Shipton et al., 2009), but as there were 
no teenagers included and less than one 
per cent of the sample were pregnant at 
the time of interview, this reporting bias 
should not influence our results to any 
large extent. Further, since smoking was 
less stigmatized at the time of the data col-
lection, the risk of people underreporting 
their actual smoking behaviour is possibly 
reduced.
One limitation is that the records are 
from only a three-wave panel within a 
fourteen year period, and thus provide 
less information about the two intervening 
periods. The problem of “heaping” (i.e. 
the tendency that people report “round” 
numbers, see e.g. Bar and Lilliard, 2012) 
could in our case relate both to the num-
ber of reported years since they started to 
smoke and to the number of years since the 
quitters gave up their habit. As we have 
split the smokers into groups depending 
on their pre-sampling smoking career and 
have set the categories so that they com-
prise the “round” numbers (5, 10, 15, and 
20) as well as the numbers nearby, the po-
tential effect of the first type of “heaping” 
should be substantially reduced. Further, 
“heaping” with respect to the number of 
years since quitting is probably less prob-
lematic here than in other datasets, as 
the relevant retrospective period at each 
screening interview was relatively short 
(less than 6 years for most quitters). 
The data may, of course, be criticised for 
being somewhat old and to some extent 
outdated. Although important smoking re-
lated factors have changed since the start 
of the study period (new cessation prod-
ucts have become available, the knowl-
edge and focus of health-damaging effects 
of smoking has increased, new restric-
tions have been introduced, etc.) it seems 
likely that the structural findings still ap-
ply. Participation in a screening program 
may constitute a “teachable moment” for 
smokers as it may “motivate individuals to 
spountanously adopt risk-reducing health 
behaviours” (McBride, Emmons, & Lip-
kus, 2003; Taylor et al., 2007).
Despite intensified actions for reduc-
ing tobacco consumption there are still 
millions of daily cigarette smokers. Given 
that further extensions of many traditional 
interventions have little political appeal, 
alternative approaches to reduce smoking 
are much wanted by the health authori-
ties. The significant effect of being invited 
to and participating in a screening appears 
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1974–1975, 1977–1978, 1987–1988.
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smoking information that encompassed 
their smoking status one year prior to the 
screening, we started the panel in 1974 for 
those screened in 1975, in 1975 for those 
screened in 1976, etc.
3 For a fraction of the respondents this 
information could not be used due to obvi-
ous measurement errors. To avoid possible 
selection bias, these subjects (8.8%) were 
assigned a randomly picked year of smok-
ing cessation within the 1–5 year interval. 
To test the sensitivity of the assignment we 
re-ran the estimations for the three groups 
excluding this subgroup of quitters. The 
estimates remained roughly unchanged 
and the hazard ratios of screening were still 
highly significant and their value increased 
for all groups.
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Appendix: Model and method 
We employ a discrete-time hazard model, with τ denoting the first observation year and t the 
running calendar year, index the individual smokers by i (i=1, 2,…, n ) and analyse the stock 
of persons conditional on already being a smoker (see Lancaster, 1990, p. 91 and Verbeek, 
2004, p. 247). The observation period for individual i extends from period t=τ till period 
t=τ+si. Its length is i-dependent both because a person was dropped from further follow-up 
from the year he/she ceased smoking (uncensored cases, δi=1) and because the the study 
design implied that the follow-up period differed among those who continued smoking 
(censored cases, δi=0).  
 
Letting  and  ( < τ < ) represent the calendar periods in which individual i begins and 
ends smoking, respectively, the hazard rate for year t, i.e., the probability that smoker i quits 
in year t, conditional on having started in period  and having smoked until period t, is 
( )       (    |         )                
 
Since the probability that smoker i did not cease smoking in period t is (1- hi,t), the conditional 
probability of observing the event history in the case of continued smoking throughout the 
observation window [τ, τ+si] is:  
( )          (       |         )  ∏(      )
    
   
  
 
Using (1) and (2), the probability that individual i quits smoking during the study interval is  
( )  (       |         )                           ∏ (      ) 
      
   

Combining (2) and (3), the log-likelihood can be expressed as  
   ( )  ∑ 
 
   
      
       
(         )
  ∑    (      )  
    
   
  
 
Defining yit = 1 if t=τ+si & δi=1, and yit = 0 otherwise, we can rewrite the latter expression 
more conveniently as (see Jenkins 1995, section II):  
iB iT iB iT
iB
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( )    ( )  ∑∑  
   
    
    
(      )
  
    
   
    (     ) 
 
   
   
  
To parameterize     we chose the cloglog function, which implies that the complementary, 
continue smoking, probability is 
                                     (     )         
Here is a linear function of observed covariates xit, and the duration dependence, ϴ(t). In 
modelling     two time variables are involved: time in process as a smoker and time in the 
screening process, because a respondent’s inclination to cease smoking is likely to depend on 
how long he/she (i) has been addicted to smoking and (ii) has been scrutinized by health 
authorities and thereby has accumulated health screening information. We model ϴ(t) 
flexibly, using a piecewise constant function based on year dummies, allowing for stepwise 
changes in the coefficient vector by splitting the sample according to the length of the 
smoking career (SC) before observation starts, i.e., = τ - .  
 
Denoting the coefficient vectors of xit and ϴ(t) by, respectively,  and µj, if the length of the 
pre-sample smoking career belongs to the j‘th interval Ij (ST-, MT- and LT-smokers, 
respectively), letting εi, represent unobserved heterogeneity, we have  
( )              (     )    
       
  ( )                 
Since the Akaike and the Bayesian information criteria (AIC and BIC) suggested that in 
modelling heterogeneity, the gamma distribution was superior to the normal and the discrete 
multinomial distribution, the results presented in section 3 are based on a cloglog model with 
   following the former distribution.  
 
itz
iSC iB
j
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Appendix Table A1 Variable description
Variables Operationalization Type* Data source**
interventions
Screening1 Dummy; 1 in the time period of R1 6 H.P, screening
Screening2 Dummy; 1 in the time period of R2 7 H.P, screening
Screening3 Dummy; 1 in the time period of R3 8 H.P, screening
Demographics
Male Dummy;1 if male 2 H.P, screening
Age Age at start of survey 1 Time invariant S.R, screening
Educ1 Dummy; 1 if highest education is min. schooling (mandatory) 3 Statistics Norway
Educ2 Dummy; 1 if highest education is secondary school 3 Statistics Norway
Educ3 Dummy; 1 if between 12 and 15 years of schooling 3 Statistics Norway
Educ4 Dummy; 1 if highest education is university degree 3 Statistics Norway
Children Dummy; 1 if having children under the age of 16 Time varying Statistics Norway
New Baby Dummy; 1 if having a new baby Time varying Statistics Norway
Single Dummy; 1 if not registered with spouse or cohabitant Time varying Statistics Norway
Married Dummy; 1 if married Time varying Statistics Norway
Div-wid Dummy; 1 if divorced, separated or widowed Time varying Statistics Norway
Screening2 Dummy; 1 in the time period of R2 7 H.P, screening
Screening3 Dummy; 1 in the time period of R3 8 H.P, screening
Health
Symptm (R1) Dummy; 1 if symptoms of heart/lung illness (R1) 2 S.R, screening
Illness (R1) Dummy; 1 if having heart/lung illness (R1) 2 S.R, screening
Bmihigh (R1) Dummy; 1 if body mass index >25 (R1) 2 H.P, screening
Actwork(R1) Dummy; 1 if having physical demanding work (R1) 2 S.R, screening
Exercise (R1) Dummy; 1 if exercising at least 4 hours per week (R1) 2 S.R, screening
Disabled (R1) Dummy; 1 if receiving disability benefit (R1) 2 S.R, screening
Sympchange12 Dummy; 1 if new symptoms are reported in R2 4 S.R, screening
Sympchange23 Dummy; 1 if new symptoms are reported in R3 5 S.R, screening
Illchange12 Dummy; 1 if new heart/lung illnesses are reported in R2 4 S.R, screening
Illchange23 Dummy; 1 if new heart/lung illnesses are reported in R3 5 S.R, screening
Badreport1 Dummy; 1 if score above cut-off, blood tests or x-ray, in R1 6 H.P, screening
Badreport2 Dummy; 1 if score above cut-off, blood tests or x-ray, in R2 7 H.P, screening
Addiction
Smokeage Age when started to smoke 2 S.R, screening
Number_cig Ln of max reported cigarettes smoked per day Time invariant S.R, screening
Economic
Cigprice Ln of the difference of CPI adjusted price (P1975-P1974) Time varying Statistics Norway
Income Ln of CPI adjusted family income Time varying Statistics Norway
Dependent var.
Quit smoking Dummy; 1 if quitting smoking 1 S.R, screening
*For dummy variables, see Table A2 for explanation
** S.R= self reported, H.P = registered by health personnel
Unauthenticated
Download Date | 1/7/15 1:23 PM
160 NORDIC STUDIES ON ALCOHOL AND DRUGS   V O L .  31.  2 0 1 4  . 2 
Appendix Table A2 Types of dummy variables 
Time period Year 1i 2ii 3iii 4iv 5iv 6v 7v 8v
1 1974 0 1 0 0 0 0 0 0
2 1975, 1. screening 0 1 0 0 0 1 0 0
3 1976 0 1 0 1 0 0 0 0
4 1977 0 1 0 1 0 0 0 0
5 1978 0 1 0 1 0 0 0 0
6 1979 1 1 0 1 0 0 0 0
7 1980, 2. screening . 1 0 1 0 0 1 0
8 1981 . 1 0 0 1 0 0 0
9 1982 . 1 0 0 1 0 0 0
10 1983 . 1 1 0 1 0 0 0
11 1984 . 1 1 0 1 0 0 0
12 1985 . 1 1 0 1 0 0 0
13 1986, 3. screening . 1 1 0 1 0 0 1
14 1987 . . . . . . . .
15 1988 . . . . . . . .
i) The vector exemplifies an individual who quits smoking in 1979.
ii) The vector exemplifies a dummy that is time-invariant for the whole period (e.g. male, started to smoke at an early age, 
etc.) 
iii) The vector exemplifies an individual who changes status in 1983 (e.g. become divorced this year)
iv) The vectors exemplifies an individual who has changed health status between two screenings (Sympchange 12, 23 
and Illchange 12, 23)
v) The vector exemplifies an individual who has been screened in 1975, 1980 and 1986.
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